Oncopharmpod
Viz-Aflibercept Pricing: A Case Study
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:07
- Mas informaciones
Informações:
Sinopsis
Looking back at a 2012 NYT op-ed (https://www.nytimes.com/2012/10/15/opinion/a-hospital-says-no-to-an-11000-a-month-cancer-drug.html) that led to a 50% price decrease in a biologic cancer medication.
